Clinical Trial Update: Safety and Efficacy of Gene Modified Autologous Hematopoietic Stem Cells to Treat Transfusion-dependent Beta-thalassemia [NA]

View source ↗

Summary

This entry notes a clinical trial evaluating safety and efficacy of gene-modified autologous hematopoietic stem cells in transfusion-dependent beta-thalassemia;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Beta-thalassemia

Drugs mentioned

• Gene-modified autologous hematopoietic stem cell therapy (gene-modified autologous hematopoietic stem cells)

Snippet

Sponsor: Shanghai BDgene Co., Ltd. | Conditions: β-thalassemia | NA | Status: RECRUITING